🇺🇸 FDA
Patent

US 8821926

Tablet containing hardly soluble active ingredient

granted A61KA61K31/407A61K9/2054

Quick answer

US patent 8821926 (Tablet containing hardly soluble active ingredient) held by Takeda Pharmaceutical Company Limited expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/407, A61K9/2054, A61K9/284, A61K9/2866